NeuroNascent, Inc. - Neurogenesis, Neurodegeneration, Alzheimer's Disease, Stroke, Depression, Hibernation, Maryland Biotech, small molecule therapeutics, Neuron

Management Team

Directors & Advisors

Collaborators

Memberships

< back to Management Team

Judith Kelleher-Andersson, Ph.D.
President and Chief Scientific Officer (CSO)

Dr. Kelleher-Andersson has over twelve years of experience developing small-molecule, central nervous system therapeutics in the biotechnology industry. Prior to founding Neuronascent, she was Director of Drug Development and Research at Neuralstem, Inc., Centaur Pharmaceuticals and Cortex Pharmaceuticals, Inc. She headed the Alzheimer's disease program in collaboration with Astra-Zeneca while at Centaur, and successfully brought a small-molecule agent to pre-nomination status. Dr. Kelleher-Andersson has over 70 US, European and World patents. She received her Ph.D. in biochemistry from University of Missouri-Columbia and completed post-graduate work at UCLA and University of California, San Francisco.